Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Medicine

• Publication date

  2012-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amjmed.2012.07.015PMID 23164485
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Utility of Absolute and Relative Changes in Cardiac Troponin Concentrations in the Early Diagnosis of Acute Myocardial Infarction

  2011cited by this paper
• Comparison of prognostic value of high-sensitivity and conventional troponin T in patients with non-ST-segment elevation acute coronary syndromes.

  2011cited by this paper
• Population trends in the incidence and outcomes of acute myocardial infarction.

  2010cited by this paper
• Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay.

  2010cited by this paper
• Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.

  2010cited by this paper
• Recommendations for the use of cardiac troponin measurement in acute cardiac care.

  2010cited by this paper
• The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes.

  2010cited by this paper
• Analytical validation of a high-sensitivity cardiac troponin T assay.

  2010cited by this paper
• Implementation of high sensitivity cardiac troponin T measurement in the emergency department.

  2010cited by this paper
• Will the universal definition of myocardial infarction criteria result in an overdiagnosis of myocardial infarction?

  2009cited by this paper
• Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice.

  2009cited by this paper
• Clinical application of sensitive troponin assays.

  2009cited by this paper
• Early diagnosis of myocardial infarction with sensitive cardiac troponin assays.

  2009cited by this paper
• Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population.

  2009cited by this paper
• A sensitive cardiac troponin T assay in stable coronary artery disease.

  2009cited by this paper
• Long-Term Trends in Myocardial Infarction Incidence and Case Fatality in the National Heart, Lung, and Blood Institute's Framingham Heart Study

  2009cited by this paper
• Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making.

  2009cited by this paper
• Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events.

  2009cited by this paper
• Sensitive troponin I assay in early diagnosis of acute myocardial infarction.

  2009cited by this paper
• Incremental value of copeptin for rapid rule out of acute myocardial infarction.

  2009cited by this paper
• Clinical significance of borderline elevated troponin I levels across different assays in patients with suspected acute coronary syndrome.

  2009cited by this paper
• New definition of myocardial infarction: impact on long-term mortality.

  2008cited by this paper
• Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.

  2008cited by this paper
• Universal definition of myocardial infarction.

  2007cited by this paper
• Long-term health outcomes associated with detectable troponin I concentrations.

  2007cited by this paper
• A personal history of markers of myocyte injury [myocardial infarction].

  2007cited by this paper
• National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes.

  2007cited by this paper
• Universal definition of myocardial infarction.

  2007cited by this paper
• Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure

  2007cited by this paper
• Chasing troponin: how low can you go if you can see the rise?

  2006cited by this paper
• Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate

  2006cited by this paper
• Cardiac biomarkers for detection of myocardial infarction: perspectives from past to present.

  2004cited by this paper
• Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients.

  2004cited by this paper
• European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials.

  2002cited by this paper
• Erratum: Myocardial infarction redefined - A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (Journal of the American College of Cardiology (2000) 36 (959-969))

  2001cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature.

  1979cited by this paper

• Meta-analysis of magnetocardiography in diagnosing coronary artery disease and myocardial ischemia

  2026cites this paper
• Pre-Hospital Point-of-Care Troponin: Is It Possible to Anticipate the Diagnosis? A Preliminary Report

  2025cites this paper
• Zero Coronary Artery Calcification: A Promising Value in Acute Chest Pain Evaluation

  2025cites this paper
• Emergency Department Implementation of a Multimodal Electronic Health Record–Integrated Clinical Intervention for High-Sensitivity Troponin Testing Increases Diagnostic Efficiency

  2025cites this paper
• National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025.

  2025cites this paper
• Clinical outcome of older adults developing acute coronary syndrome during hospitalization for noncardiac illness: A prospective observational study

  2025cites this paper
• Diagnosis, risk stratification, and early management of non-ST-segment elevation acute coronary syndrome.

  2025cites this paper
• Observational analysis of non-ST-segment elevation myocardial infarction invasive management and mortality over the decades

  2025cites this paper
• Lack of Change in the Incidence of Unstable Angina after Transition to High-Sensitivity Cardiac Troponin T.

  2025cites this paper
• Performance Status of Older Adults Who Developed Acute Coronary Syndrome during Hospitalization for Noncardiac Illness and Their Clinical Outcome: A Prospective Observational Study

  2025cites this paper
• Artificial Intelligence and Its Role in the Diagnosis and Prediction of Adverse Events in Acute Coronary Syndrome: A Narrative Review of the Literature

  2025cites this paper
• Diagnose und Triage

  2024cites this paper
• Platelet Glycoprotein IIIa PlA1/PlA2 Polymorphism Modulates the Risk of Myocardial Infarction in Non-Diabetics

  2024cites this paper
• Diagnosis of acute myocardial infarction in patients with renal failure using high-sensitivity cardiac troponin T.

  2024cites this paper
• Comparative Analysis of Abnormal Troponin and ST Deviations in Diagnosis of Myocardial Infarction

  2024cites this paper
• Prognostic Value and Determinants of High‐Sensitivity Cardiac Troponin T in Patients With a Systemic Right Ventricle: Insights From the SERVE Trial

  2024influential citation
• Vascular disease and ischemic stroke in patients with atrial fibrillation: Temporal trends and age-related differences.

  2024cites this paper
• Depression among older adults who developed acute coronary syndrome (ACS) during hospitalization for non-cardiac illness: A prospective observational study

  2024cites this paper
• Frailty among Older Adults Who Developed Acute Coronary Syndrome during Hospitalization for Noncardiac Illness and Their Outcome: A Prospective Observational Study

  2024cites this paper
• Comparative Ten-Year Outcomes in Chronic and Acute Coronary Syndrome Patients Undergoing Invasive Diagnostics—Insights from the KORONEF Registry

  2024cites this paper
• Unstable Angina Risk Stratification using High-sensitivity Cardiac Troponin and Coronary Angiography.

  2024cites this paper
• High-Sensitivity Cardiac Troponin T Reporting, Clinical Outcomes, and Health Care Resource Use

  2024cites this paper
• Temporal trends in concordance between ICD-coded and cardiac biomarker-classified hospitalisation rates for acute coronary syndromes: a linked hospital and biomarker data study

  2024cites this paper
• High medium-term incidence of major cardiovascular events in discharged patients with unstable angina

  2023cites this paper
• Electrocardiogram-based deep learning algorithm for the screening of obstructive coronary artery disease

  2023cites this paper
• Soluble urokinase plasminogen activator receptor and survival in elective cardiac surgery

  2023cites this paper
• Circulating forms of cardiac troponin: a review with implications for clinical practice

  2023cites this paper
• Development of saliva-based cardiac troponin I point-of-care test using alpha-amylase depletion: a feasibility study

  2023cites this paper
• Correlations between high sensitive troponin I and acute myocarditis extent in cardiac magnetic resonance imaging

  2023cites this paper
• Risk stratification of patients with chest pain who have an unscheduled revisit to the emergency department.

  2023cites this paper
• 2023 ESC Guidelines for the management of acute coronary syndromes.

  2023cites this paper
• Coronary computed tomography angiography in the evaluation of acute chest pain in patients with elevated high sensitive cardiac troponin I (hs-cTn) level

  2023cites this paper
• Role of inflammation following an acute myocardial infarction: design of INFINITY.

  2023cites this paper
• Type 2 Myocardial Infarction: Do We Need Risk Scores?

  2023influential citation
• Time to coronary catheterization in patients with non-ST-segment elevation acute coronary syndrome and high Global Registry of Acute Coronary Events score

  2023cites this paper
• Plasma levels of high-sensitivity cardiac troponin i and histopathological findings in heart transplant patients: A single-center cross-sectional study

  2023cites this paper
• Assessment of In-Hospital Mortality and Its Risk Factors in Patients with Myocardial Infarction Considering the Logistical Aspects of the Treatment Process—A Single-Center, Retrospective, Observational Study

  2023cites this paper
• Temporal trends in mortality and provision of intensive care in younger women and men with acute myocardial infarction or stroke

  2023cites this paper
• High-Sensitivity Cardiac Troponin Assays: Ready for Prime Time!

  2023cites this paper
• Marqueurs biologiques aux urgences

  2023cites this paper
• Trends in the incidence and in-patient outcomes of acute myocardial infarction in pregnancy: Insights from the national inpatient sample

  2023cites this paper
• 2023 ESC Guidelines for the management of acute coronary syndromes.

  2023cites this paper
• Temporal Changes of Stable High‐Sensitivity Cardiac Troponin T Levels and Prognosis

  2022cites this paper
• Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and Cons

  2022cites this paper
• A Malaysian Expert Consensus on the Use of High-sensitivity Cardiac Troponin in the Emergency Department

  2022cites this paper
• Association between symptoms and risk of non-ST segment elevation myocardial infarction according to age and sex in patients admitted to the emergency department with suspected acute coronary syndrome: a single-centre retrospective cohort study

  2022cites this paper
• In‐hospital outcomes of patients with a hypertensive emergency at a medical center, Ethiopia: A prospective observational study

  2022cites this paper
• Prevalence and characteristics of non-ST-segment elevation in acute myocardial infarction with insignificant coronary artery disease

  2022influential citation
• Type 2 myocardial infarction: a diagnostic and therapeutic challenge in contemporary cardiology

  2022cites this paper
• FREQUENCY OF LEFT VENTRICLE THROMBUS IN PATIENT WITH ACUTE ANTERIOR WALL MYOCARDIAL INFARCTION

  2022cites this paper
• Serial troponin-T and long-term outcomes in suspected acute coronary syndrome.

  2022cites this paper
• Methods of screening, monitoring and management of cardiac toxicity induced by chemotherapeutics

  2022cites this paper
• Management and outcome of patients with non-ST elevation myocardial infarction and intercurrent noncoronary precipitating events.

  2022cites this paper
• High-Sensitivity Cardiac Troponin I and T Kinetics Differ following Coronary Bypass Surgery: A Systematic Review and Meta-Analysis.

  2022cites this paper
• Outcomes after coronary angiography for unstable angina compared to stable angina, myocardial infarction and an asymptomatic general population

  2022cites this paper
• Absolute Versus Relative Changes in Cardiac Troponins in the Diagnosis of Myocardial Infarction: A Systematic Review and Meta-Analysis

  2022cites this paper
• Saudi Heart Association Position Statement on the Use of Biomarkers for the Management of Heart Failure and Acute Coronary Syndrome

  2022cites this paper
• Unstable Angina Pectoris With Myocardial Injury Versus Myocardial Infarction in the Era of High-Sensitivity Cardiac Troponin.

  2022cites this paper
• Computed tomography coronary angiography in non-ST-segment elevation myocardial infarction

  2022cites this paper
• Prevalence of obstructive coronary artery disease in patients with unstable angina.

  2022cites this paper
• Non-ST-Elevation Acute Coronary Syndromes

  2022cites this paper
• Acute coronary syndrome without persistent elevation of the ST segment: New recommendations

  2022cites this paper
• Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction.

  2022cites this paper
• Effects of perilipin-5 on lipid metabolism and high-sensitivity cardiac troponin I

  2022cites this paper
• Analytical and Clinical Considerations in Implementing the Roche Elecsys Troponin T Gen 5 STAT Assay.

  2021cites this paper
• Renin-angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID-19 among patients with/without hypertension

  2021cites this paper
• Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level

  2021cites this paper
• Al Wakra type II myocardial infarction-a case report in our emergency department.

  2021cites this paper
• Guía ESC 2020 sobre el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST

  2021cites this paper
• Minor troponin T elevation and mortality in patients with atrial fibrillation presenting to the emergency department

  2021cites this paper
• Kounis syndrome after a wasp sting

  2021cites this paper
• High sensitivity troponin, analytical advantages, clinical benefits and clinical challenges - an update.

  2021cites this paper
• Valor Prognóstico de Níveis Elevados de Troponina I Isolados em Pacientes sem Síndrome Coronariana Aguda Admitidos no Serviço de Emergência

  2021cites this paper
• Clinical Impact of High-Sensitivity Cardiac Troponin T Implementation in the Community.

  2021cites this paper
• Troponin I as a biomarker for early detection of Acute Myocardial Infarction.

  2021cites this paper
• Gestione di un dolore toracico in Pronto Soccorso

  2021cites this paper
• Preliminary data from the retrospective and prospective observational studies on nSTEMI patient management in Moldova

  2021cites this paper
• Prise en charge d’une douleur thoracique aux urgences

  2021cites this paper
• The change in high-sensitivity troponin-T as a risk factor for significant coronary stenosis in patients with acute coronary syndrome

  2021influential citation
• Implementation of more sensitive cardiac troponin T assay in a state-wide health service.

  2021cites this paper
• Novel Criteria for the Observe-Zone of the ESC 0/1h-hs-cTnT Algorithm

  2021cites this paper
• Diagnostic Performance of Novel Troponin Algorithms for the Rule-Out of Non-ST-Elevation Acute Coronary Syndrome.

  2021cites this paper
• High-sensitivity methods for cardiac troponins: The mission is not over yet.

  2021cites this paper
• Safely Ruling Out Myocardial Infarction Using a Single Cutoff Troponin Measurement.

  2020cites this paper
• High-Sensitivity Troponin T Testing: Consequences on Daily Clinical Practice and Effects on Diagnosis of Myocardial Infarction

  2020cites this paper
• Fokussierte transthorakale Echokardiographie bei Patienten mit akutem Koronarsyndrom (ACS) in der präklinischen Notfallmedizin

  2020cites this paper
• Cardiac Troponin Assays With Improved Analytical Quality: A Trade‐Off Between Enhanced Diagnostic Performance and Reduced Long‐Term Prognostic Value

  2020cites this paper
• No increase in the incidence of cardiac troponin i concentration above the 99th percentile by siemens centaur high-sensitivity compared to the contemporary assay.

  2020cites this paper
• The IFCC Clinical Application of Cardiac Biomarkers Committee's Appraisal of the 2020 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation: Getting Cardiac Troponin Right.

  2020cites this paper
• Is the true clinical value of high-sensitivity troponins as a biomarker of risk? The concept that detection of high-sensitivity troponin ‘never means nothing’

  2020cites this paper
• Prise en charge d’une douleur thoracique aux urgences

  2020cites this paper
• Use of cardiac troponin in the early diagnosis of acute myocardial infarction.

  2020cites this paper
• Prehospital risk stratification in non-ST-elevation acute coronary syndrome; a paramedic echocardiography pilot study.

  2020cites this paper
• 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

  2020cites this paper
• Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort

  2020cites this paper
• Physiopathology of unstable angina in hypertensive patients and clinical risk assessment

  2020cites this paper
• The prognostic value of cardiac troponin T in different age groups of traumatic brain injury patients

  2020cites this paper
• Diagnosis and management of acute myocardial infarction: An overview

  2019cites this paper
• Causes of Death in Patients with Acute and Chronic Myocardial Injury.

  2019cites this paper
• Long-term clinical outcomes in patients with unstable angina undergoing percutaneous coronary interventions in a contemporary registry data from Poland

  2019cites this paper